Thus, it is likely that CML leukemia non-stem cells, BCR-ABL-transformed megakaryocytes, can support the leukemogenic capacity of CML LSCs by providing them with TGF-β1 (Fig. 6). This evidence concerns the gene ABL1 and leukemia.